Anacor Pharms Inc Drug Patent Portfolio

Anacor Pharms Inc owns 2 orange book drugs protected by 19 US patents Given below is the list of Anacor Pharms Inc's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8168614 Boron-containing small molecules as anti-inflammatory agents 20 Jul, 2030
Active
US8168614 Boron-containing small molecules as anti-inflammatory agents 20 Jan, 2030
Active
US8039451 Boron-containing small molecules 29 Dec, 2029
Active
US8039451 Boron-containing small molecules 29 Jun, 2029
Active
US7582621 Boron-containing small molecules 26 Nov, 2027
Active
US8501712 Boron-containing small molecules as anti-inflammatory agents 16 Aug, 2027
Active
US9682092 Boron-containing small molecules as anti-inflammatory agents 16 Aug, 2027
Active
US7582621 Boron-containing small molecules 26 May, 2027
Active
US7767657 Boron-containing small molecules 22 May, 2027
Active
US8501712 Boron-containing small molecules as anti-inflammatory agents 16 Feb, 2027
Active
US9682092 Boron-containing small molecules as anti-inflammatory agents 16 Feb, 2027
Active
US9549938 Boron-containing small molecules 16 Aug, 2026
Active
US9566289 Boron-containing small molecules 16 Aug, 2026
Active
US9566290 Boron-containing small molecules 16 Aug, 2026
Active
US9572823 Boron-containing small molecules 16 Aug, 2026
Active
US9549938 Boron-containing small molecules 16 Feb, 2026
Active
US9566289 Boron-containing small molecules 16 Feb, 2026
Active
US9566290 Boron-containing small molecules 16 Feb, 2026
Active
US9572823 Boron-containing small molecules 16 Feb, 2026
Active


Given below is the list of recent legal activities going on the following drug patents of Anacor Pharms Inc.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 12 Oct, 2023 US8168614
Payment of Maintenance Fee, 12th Year, Large Entity 09 Mar, 2023 US8039451
Application Return TO OIPE 18 Jul, 2022 US9566290
Application Return from OIPE 18 Jul, 2022 US9566290
Correspondence Address Change 18 Jul, 2022 US9566290
Payment of Maintenance Fee, 12th Year, Large Entity 13 Jan, 2022 US7767657
Patent Term Extension Certificate 10 Dec, 2021 US8039451
Maintenance Fee Reminder Mailed 19 Apr, 2021 US7582621
Review Certificate Mailed 16 Apr, 2021 US9572823
Review Certificate Mailed 08 Apr, 2021 US9566289
Review Certificate Mailed 08 Apr, 2021 US9566290
Review Certificate Mailed 08 Apr, 2021 US9549938
Review Certificate 19 Mar, 2021 US9549938
Review Certificate 19 Mar, 2021 US9566290
Review Certificate 19 Mar, 2021 US9566289


Anacor Pharms Inc's Drug Patent Litigations

Anacor Pharms Inc's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Aug 20, 2015, against patent number US7767657. The petitioner Coalition for Affordable Drugs X, LLC, challenged the validity of this patent, with Anacor Pharmaceuticals, Inc. as the respondent. Click below to track the latest information on how companies are challenging Anacor Pharms Inc's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US9549938 November, 2017 FWD Entered
(05 Jun, 2019)
Anacor Pharmaceuticals, Inc. FlatWing Pharmaceuticals, LLC
US9566289 November, 2017 FWD Entered
(05 Jun, 2019)
Anacor Pharmaceuticals, Inc. FlatWing Pharmaceuticals, LLC
US9566290 November, 2017 FWD Entered
(05 Jun, 2019)
Anacor Pharmaceuticals, Inc. FlatWing Pharmaceuticals, LLC
US9572823 November, 2017 FWD Entered
(05 Jun, 2019)
Anacor Pharmaceuticals, Inc. FlatWing Pharmaceuticals, LLC
US9549938 July, 2018 Terminated
(11 Oct, 2018)
Pfizer Inc. Mylan Pharmaceuticals Inc. et al.
US9566289 July, 2018 Terminated
(11 Oct, 2018)
Pfizer Inc. Mylan Pharmaceuticals Inc. et al.
US9566290 July, 2018 Terminated
(11 Oct, 2018)
Pfizer Inc. Mylan Pharmaceuticals Inc. et al.
US9572823 July, 2018 Terminated
(11 Oct, 2018)
Pfizer Inc. Mylan Pharmaceuticals Inc. et al.
US7582621 August, 2015 FWD Entered
(23 Feb, 2017)
Anacor Pharmaceuticals, Inc. Coalition for Affordable Drugs X LLC
US7767657 August, 2015 FWD Entered
(23 Feb, 2017)
Anacor Pharmaceuticals, Inc. Coalition for Affordable Drugs X, LLC


Anacor Pharms Inc's Family Patents

Anacor Pharms Inc drugs have patent protection in a total of 27 countries. It's US patent count contributes only to 27.2% of its total global patent coverage. Click below to unlock the full patent family tree.

Family Patents



Anacor Pharms Inc Drug List

Given below is the complete list of Anacor Pharms Inc's drugs and the patents protecting them.


1. Eucrisa

Eucrisa is protected by 8 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8168614
(Pediatric)
Boron-containing small molecules as anti-inflammatory agents 20 Jul, 2030
(5 years from now)
Active
US8168614 Boron-containing small molecules as anti-inflammatory agents 20 Jan, 2030
(5 years from now)
Active
US8039451
(Pediatric)
Boron-containing small molecules 29 Dec, 2029
(5 years from now)
Active
US8039451 Boron-containing small molecules 29 Jun, 2029
(4 years from now)
Active
US8501712
(Pediatric)
Boron-containing small molecules as anti-inflammatory agents 16 Aug, 2027
(2 years from now)
Active
US9682092
(Pediatric)
Boron-containing small molecules as anti-inflammatory agents 16 Aug, 2027
(2 years from now)
Active
US8501712 Boron-containing small molecules as anti-inflammatory agents 16 Feb, 2027
(2 years from now)
Active
US9682092 Boron-containing small molecules as anti-inflammatory agents 16 Feb, 2027
(2 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Eucrisa's drug page


2. Kerydin

Kerydin is protected by 11 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7582621
(Pediatric)
Boron-containing small molecules 26 Nov, 2027
(3 years from now)
Active
US7582621 Boron-containing small molecules 26 May, 2027
(2 years from now)
Active
US7767657 Boron-containing small molecules 22 May, 2027
(2 years from now)
Active
US9549938
(Pediatric)
Boron-containing small molecules 16 Aug, 2026
(1 year, 10 months from now)
Active
US9566289
(Pediatric)
Boron-containing small molecules 16 Aug, 2026
(1 year, 10 months from now)
Active
US9566290
(Pediatric)
Boron-containing small molecules 16 Aug, 2026
(1 year, 10 months from now)
Active
US9572823
(Pediatric)
Boron-containing small molecules 16 Aug, 2026
(1 year, 10 months from now)
Active
US9549938 Boron-containing small molecules 16 Feb, 2026
(1 year, 4 months from now)
Active
US9566289 Boron-containing small molecules 16 Feb, 2026
(1 year, 4 months from now)
Active
US9566290 Boron-containing small molecules 16 Feb, 2026
(1 year, 4 months from now)
Active
US9572823 Boron-containing small molecules 16 Feb, 2026
(1 year, 4 months from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Kerydin's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List